• Mark Terry
• 04 Jan, 2019

Selecta Biosciences, based in Watertown, Mass., announced that as part of restructuring efforts it is cutting its current workforce by 36 percent. The company believes that the cuts, along with a reprioritization of its pipeline, will decrease its yearly cash burn by 19 percent. At its third-quarter financial report on November 8, 2018, the company reported no revenue for the quarter, while R&D expenses were $11.9 million, up from $9.5 million in the same quarter in 2017.
Read more...